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Background
Lung cancer patients may inappropriately receive
systemic anti-cancer therapy (SACT) when they are
close to end of life, despite evidence that early palliative
intervention can led to less aggressive care and longer
survival [1]. The National Confidential Enquiry into
Patient Outcome and Death made the recommendation
that acceptance of treatment/treatment decision should
be made by the patient after they have been fully
informed of the risks and benefits [2].
Aims
To identify the information and decision support needs
of patients and to design an intervention to facilitate
discussion of the risks and benefits of the available treat-
ment options.
Methods
Observations of interactions at MDT meetings and
patient-clinician consultations (n=20-30) will identify
how patients are allocated to treatment pathways, how
treatment management options are presented to patients
and the extent of patient involvement in treatment plan-
ning. Semi-structured face-to-face interviews with
patients and clinicians will explore perceptions of the
treatment management options, and attitudes and per-
ceived involvement in treatment decisions. These data
will be used to inform the design, development and sub-
sequent evaluation of the intervention, including an
appropriate theoretical basis.
Results and conclusions
Data collection will commence in the autumn of 2013.
We anticipate the data to provide an insight into why
lung cancer patients may receive SACT when palliative
care may perhaps be more appropriate. The resulting
intervention will be made available to patients and clini-
cians to provide information and support when consid-
ering uptake of SACT for lung cancer.
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